Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation TCT 2025

Placebo-Controlled Interventional Trials: A Sham No More

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation Controversies and Advances 2025

The role of double-blind sham-controlled trials in interventional cardiology

Presenter: Rasha Al-Lamee

January 31, 2025

Presentation Controversies and Advances 2025

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Presenter: Rasha Al-Lamee

January 31, 2025

Presentation TCT 2024

Coronary Microvascular Disease -- How Do We Move the Field Forward?

Presenter: Rasha Al-Lamee

October 30, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation TCT 2023

My Step-by-step Approach to Avoid Common Mistakes in Measuring Invasive Physiology

Presenter: Rasha Al-Lamee

October 26, 2023

Presentation TCT 2022

Case-Based Presentation: Sex-Specific Considerations of Physiologic Assessment of CAD in the Cath Lab

Presenter: Rasha Al-Lamee

September 17, 2022

Presentation TCT 2021

Evidence Gaps: What’s Needed in the New Guidelines?

Presenter: Rasha Al-Lamee

November 05, 2021

Presentation TCT 2018

Assessing Chest Pain With Invasive Physiology: Lessons From Orbita and Other Studies

Presenter: Morton J. Kern, Jan J. Piek, Rasha Al-Lamee

September 24, 2018

Presentation TCT 2018

Physiology Case Vignette #8: IMR Made the Diagnosis!

Presenter: Morton J. Kern, Jan J. Piek, Rasha Al-Lamee, Giuseppe De Luca, Ole Fröbert, Zsolt Piroth, Afzalur Rahman, Tim P. Van de Hoef

September 24, 2018

Presentation TCT 2018

Physiology Case Vignette #7: Combined Pressure/Flow in Practice

Presenter: Morton J. Kern, Jan J. Piek, Rasha Al-Lamee, Giuseppe De Luca, Ole Fröbert, Zsolt Piroth, Afzalur Rahman, Tim P. Van de Hoef

September 24, 2018

Presentation TCT 2018

ORBITA in the Spotlight: How I Interpret ORBITA as an Interventional Cardiologist

Presenter: Ajay J. Kirtane, Stuart J. Pocock, Rasha Al-Lamee

September 23, 2018

Presentation TCT 2018

ORBITA One Year Later: What Would I Do Differently, If Anything?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee

September 23, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow

Presenter: Rasha Al-Lamee

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

Presenter: Rasha Al-Lamee

May 05, 2018

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

Presentation TCT 2012

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

Presenter: Rasha Al-Lamee

October 23, 2012

Advertisement

Placebo-Controlled Interventional Trials: A Sham No More

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

The role of double-blind sham-controlled trials in interventional cardiology

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Coronary Microvascular Disease -- How Do We Move the Field Forward?

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

My Step-by-step Approach to Avoid Common Mistakes in Measuring Invasive Physiology

Case-Based Presentation: Sex-Specific Considerations of Physiologic Assessment of CAD in the Cath Lab

Evidence Gaps: What’s Needed in the New Guidelines?

Assessing Chest Pain With Invasive Physiology: Lessons From Orbita and Other Studies

Physiology Case Vignette #8: IMR Made the Diagnosis!

Physiology Case Vignette #7: Combined Pressure/Flow in Practice

ORBITA in the Spotlight: How I Interpret ORBITA as an Interventional Cardiologist

ORBITA One Year Later: What Would I Do Differently, If Anything?

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content